1. Acute arterial events across all vascular territories in the FOURIER trial. (14th October 2021) Authors: Oyama, K; Giugliano, R; Tang, M; Bonaca, M; Saver, J; Murphy, S; Ruzza, A; Sever, P; Sabatine, M; Bergmark, B Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cardiovascular benefit of lowering LDL-C below 1 mmol/L (40 mg/dl). (14th October 2021) Authors: Marston, N A; Giugliano, R P; Park, J G; Ruzza, A; Sever, P S; Keech, A C; Sabatine, M S Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evolocumab treatment reduces carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia. (3rd October 2022) Authors: Wiegman, A; Ruzza, A; Hovingh, G K; Santos, R D; Mach, F; Stefanutti, C; Luirink, I; Bridges, I; Wang, B; Bhatia, A K; Raal, F J; Kastelein, J J P; Gaudet, D Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗